CBIO
NASDAQ · Biotechnology
Crescent Biopharma Inc
$16.67
+0.24 (+1.46%)
Open$16.91
Previous Close$16.43
Day High$17.11
Day Low$16.56
52W High$27.41
52W Low$8.72
Volume—
Avg Volume271.2K
Market Cap610.27M
P/E Ratio—
EPS$-12.25
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+65.9% upside
Current
$16.67
$16.67
Target
$27.66
$27.66
$15.31
$27.66 avg
$30.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.12M | 57.99M | 51.60M |
| Net Income | -548,215,085 | 180.8K | 210.8K |
| Profit Margin | -1,438.1% | 0.3% | 0.4% |
| EBITDA | -536,284,154 | 390.2K | 358.0K |
| Free Cash Flow | — | 84.1K | 101.4K |
| Rev Growth | +413.7% | +8.6% | +24.1% |
| Debt/Equity | — | 0.52 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |